🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-522135-34-00
Completed Phase III

The effect of a superficial parasternal intercostal plane block in cardiac surgical patients undergoing conventional median sternotomy: a multicentric, double-blind, prospective, randomized controlled superiority trial.

2025-522135-34-00 · tracked via the Priya Life Science EU tracker
Sponsor
UZ Leuven
Sponsor type
Hospital/Clinic/Other health care facility
Therapeutic area
Anesthesia and Analgesia
Decision date
01/10/2025
Enrollment target
136
Sites
Belgium

Condition studied

Patients undergoing cardiac surgery through conventional median sternotomy access

Investigational medicinal product(s)

MINI-PLASCO NACL B. BRAUN 09 %oplossing voor injectieNaropin® 75 mg/ml Amp. 20 ml Injektionslösung

Eligibility

Age group
18-64 years, 65+ years
Sex
Female, Male

Primary endpoint

The primary outcome is the mean difference in QoR-15NL score between the verum bilateral SPIP block (intervention group) and the placebo bilateral SPIP block (control group) in patients undergoing cardiac surgery via conventional median sternotomy on the first postsurgical day, defined as 24 hours after surgical incision, assessed by the Dutch Quality of Recovery 15 items questionnaire.

Endpoint detail

The cumulative opioid consumption in the first 72 hours after surgical incision, Time to first rescue analgesia for breakthrough pain (e.g. oxycodone or piritramide) in the first 72 hours after surgical incision (in minutes)., The AUC of the reported dynamic NRS scores at predefined timepoints (assessed at 3, 6, 12, 24, 48, 72 hours) during the first 72 hours after surgical incision., The AUC of the reported dynamic NRS scores at predefined timepoints (assessed at 3, 6, 12, 24, 48, 72 hours) during the first 72 hours after surgical incision., Number of patients with PONV in the first 24 hours after surgical incision, Time spent in the ICU/PACU until fit for discharge (in hours)., Time spent in the hospital between surgical incision and the first hospital discharge (in hours)., Occurrence of respiratory complications, leading to non-invasive ventilation (NIV) or high-flow nasal cannula (HFNC) oxygen therapy, orotracheal intubation for more than 24 hours or orotracheal re-intubation, QoR-15NL score on the second (D2) after surgery, EQ-5D-5L score 30 days after surgery

Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-522135-34-00 on CTIS ↗ ← All trials in the EU